PMCPA Case
| Case number | AUTH/3870/1/24 |
| Parties | Complainant v AstraZeneca |
| Issue | Allegations about clinical trial material |
| Complaint received | 06 January 2024 |
| Completed | 20 September 2024 |
| Appeal | No appeal |
| Decision | Outwith the scope of the Code |
| Breaches | Not stated (no case report; outwith scope) |
| Sanctions | None stated |
| Additional sanctions | Not stated |
| PMCPA publication | No case summary; no case report (outwith scope) |
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Charter Member — Until 31 March
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export. £1,999/year £2,499
One real case. One key lesson. Every week — free.